Skip to content

Outcomes Of Laparoscopic Sleeve Gastrectomy In Patients With Hypothyroidism And Depression

Outcomes Of Laparoscopic Sleeve Gastrectomy In Patients With Hypothyroidism And Depression

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06859320
Enrollment
24
Registered
2025-03-05
Start date
2025-03-01
Completion date
2026-03-01
Last updated
2025-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and Obesity-related Medical Conditions

Keywords

obesity, hypothyroidism, Depression

Brief summary

Sleeve gastrectomy (SG) continues to be one of the most popular bariatric procedures all over the world. It has been established that obesity is a predisposing factor for several comorbidities, including life-threatening conditions. Many studies have discussed the impact of sleeve gastrectomy on TSH level. But, since most obese patients have some sort of depression, we will try to study the impact of sleeve gastrectomy, depression and hypothyroidism on each other.

Interventions

PROCEDURElaparoscopic sleeve gastrectomy

laparoscopic sleeve gastrectomy is one of the popular bariatric surgeries known for weight reduction

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* obese patients with depression and hypothyroidism controlled by medical treatment candidate for sleeve gastrectomy

Exclusion criteria

* patients less than 18 or above 60 * other psychiatric or medical disorders. * patients not fit for surgery * un controlled patients

Design outcomes

Primary

MeasureTime frameDescription
wound infectionfrom one day to 2 weeks post-surgerywound infection will be identified by pus in the drain or in the wound
weightfrom one day to one year after surgeryweight of the patient will be measured in Kg using weight scale
dose of thyroid replacement therapymonthly from one day to one year post surgery.the dose of L-thyroxin is monitored in microgrames
gasteric leakagefrom one day to 1 week post-surgeryleakage after surgery from staple line measured in ml in the drain
thyroid function testsfrom one day to one year after surgeryTSH,T3,T4 are measured pre and post operative
depressionfrom one day to one year after surgerydepression status is compared pre-operative and post-operative using depression questionnaire (PHQ-9)( patient health questionnaire-9)

Secondary

MeasureTime frameDescription
sex2 days pre-operativesex of patient (male or female) will be recorded before surgery
BMI ( Body Mass Index)2 days before surgery to one year after surgeryBMI is measured by the sum of weight in kg divided by the squared height in meters
age2 days pre-operativeage will be measured in years

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026